Point-of-care diagnostic market was valued at $44,240 million in 2024 and is projected to reach $85,737 million by 2035, growing at a CAGR of 6.2% from 2025 to 2035. Strategic funding from venture capitalists, healthcare institutions, and government agencies is enabling startups to commercialize and scale their technologies, driving market growth. For instance, in January 2025, Novus Diagnostics secured $4.85 million in equity financing to develop its flagship product, SepTec, a rapid point-of-care diagnostic technology platform. The funding, led by BVP Investments, Trinity Biotech, and Irrus Investments, will accelerate the development of SepTec, a tool that can diagnose and classify bloodstream infections in 15 minutes, transforming sepsis diagnosis and treatment. 

Global massive MIMO market is anticipated to grow at a CAGR of 7.4% during the forecast period (2025-2035). Government investment and support, such as NTIA's US innovation fund and government-subsidized 5G rollouts in India and China, are boosting adoption and fueling market expansion. For instance, in February 2024, Ericsson installed 100,000 Massive MIMO 5G radios for Airtel in India, illustrating its dedication to serving the nation's 65 million+ 5G subscribers. The energy-efficient Ericsson Radio System products and solutions were tested on Airtel's 5G network, marking the first implementation and validation of RedCap software in India. Airtel 5G+ service is currently available nationwide.

System-on-chip market was valued at $138,460 million in 2024 and is projected to grow at a CAGR of 8.5% from 2025 to 2035. The widespread use of generative AI models such as GPT and image synthesis requires heterogeneous SoC structures with AI accelerators, high-bandwidth memory, and optical interconnects. For instance, in April 2025, AI networking chip startup nEye Systems raised $58 million, led by Alphabet's CapitalG fund. The company is developing a chip that uses optical technology to send information between AI chips in light, a field that could lower energy use for AI data centers.

Global multi-beam antenna market is anticipated to grow at a CAGR of 8.4% during the forecast period (2025-2035). Government investment and state-sponsored programs are accelerating R&D on space-grade multi-beam technology, driving market expansion. For instance, in June 2024, SatixFy Communications secured a large order from an unidentified customer for Prime2 Space-Grade chips and software in exchange for over $20 million in payment. SatixFy's Prime2 Space-Grade chip is a digital ASIC that is optimally designed for space-grade massive MIMO antennas, revolutionizing satellite communication systems and providing the highest scalability, flexibility, and performance for multi-beam LEO or GEO aeronautical antennas.

Crop protection chemicals market was valued at $67,780 million in 2024 and is projected to reach $117,144 million by 2035, growing at a CAGR of 5.1% during the forecast period (2025–2035). The increasing demand for sustainable agriculture is primarily driven by increased ecological awareness and regulatory pressures, prompting the use of bio-based crop protection chemicals. For instance, in March 2025, Syngenta launched NETURE bioinsecticide at Expodireto, designed to help farmers manage insects affecting soybean and corn crop productivity. The bioproduct, developed from bacteria Pseudomonas chlororaphis and Pseudomonas fluorescens, offers high efficiency and residual control of pests like corn leafhoppers and stink bugs. Its versatility and compatibility with chemical pesticide formulations make it an efficient solution for producers.

The food enzymes market was valued at $2,740 million in 2024, is projected to grow to $5,521 million with a CAGR of 6.6% during the forecast period (2025–2035). The food enzymes market is tapping heavily into developments in biotechnology, enzyme engineering, and precision fermentation technologies. These advances have allowed for the manufacture of better, more stable, and more efficient enzyme formulations based on activity for food. The incorporation of genetically engineered enzymes and improved manufacturing processes has all improved the industry's ability to respond to the increased demand while maintaining product quality and consistency.

Skin cancer diagnosis and therapeutics market was valued at $14,258 million in 2024 and is projected to reach $25,160 million by 2035, growing at a CAGR of 5.3% from 2025 to 2035. This growth is driven by advancements in innovative therapies, including checkpoint inhibitors, cellular therapies, and targeted gene therapies for the treatment of melanoma. For instance, in February 2024, the FDA approved Amtagvi (lifileucel), the first cell therapy for adult patients with unresectable or metastatic melanoma. Melanoma, an ultraviolet light-related skin cancer, is responsible for a major proportion of cancer-related fatalities. Treatment can involve immunotherapy with PD-1 inhibitors and BRAF-targeting drugs. Amtagvi is an autologous tumor-derived T cell immunotherapy consisting of a patient's T cells. The treatment is the first FDA-approved tumor-derived T-cell immunotherapy in melanoma patients with high unmet medical needs.

Lung cancer therapeutics market was valued at $37,500 million in 2024 and is projected to reach $109,787 million by 2035, growing at a CAGR of 10.3% from 2025 to 2035. The market growth of innovative therapies is accelerated by FDA approval pathways, government-supported lung cancer screening programs, increased reimbursement coverage, and surrogate endpoints. For instance, in May 2025, the US FDA approved EMRELIS (Telisotuzumab Vedotin-Tllv) for adults with advanced non-small cell lung cancer (NSCLC) with high c-Met protein overexpression. It is approved by the overall response rate and duration of response. EMRELIS is a c-Met-targeted antibody-drug conjugate and the first and sole therapy ever approved for this patient population. NSCLC is the most common cause of cancer-related mortality globally, with 85% of lung cancer being identified as NSCLC.

Healthcare e-commerce market was valued at $247.0 billion in 2024 and is projected to reach $1,156.5 billion by 2035, growing at a CAGR of 18.3% from 2025 to 2035. The transition from offline to online pharmacy models, fueled by digitization penetration and telehealth solutions, is propelling market growth with real-time uploading of prescriptions, doorstep delivery, and remote consultation. For instance, in March 2025, Zeno Health launched a 50-minute medicine delivery service in Mumbai, targeting unavailability generics. With more than 180 stores acting as micro-fulfillment centers, the initiative improves healthcare affordability and accessibility.

Smart buildings market was valued at $110.4 billion in 2024 and is projected to reach $535.6 billion in 2035, growing at a CAGR of 15.5% during the forecast period (2025-2035). The future of infrastructure is determined by rising urbanization and digitization, and smart building technology is emerging as an important part of contemporary city planning. The building ecosystem is transforming owing to the increased pace of urbanization and digitalization, and the technology of smart buildings is defining the foundation of the urban build-out globally. The modern technologies at a significantly lower environmental cost improve operating performance, occupant comfort, and energy efficiency. As uptake increases in commercial, residential, and industrial applications, smart buildings are proving instrumental in driving towards environmentally friendly and intelligent constructed environments.